Table 2. Cox regression model for risk factors of intravesical recurrence.
Variable | Univariate | Multivariate | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Age | 0.984 | 0.943 - 1.029 | 0.471 | 0.961 | 0.892 - 1.035 | 0.299 |
Sex (Male vs Female) | 1.503 | 0.631 - 3.582 | 0.357 | 2.694 | 0.763 - 9.514 | 0.123 |
Stage (≥T3 vs | 1.314 | 0.597 - 2.889 | 0.497 | 0.456 | 0.093 - 2.219 | 0.330 |
Grade (3 vs 1or2) | 1.549 | 0.699 - 3.429 | 0.280 | 3.001 | 0.869 - 10.35 | 0.082 |
Hydronephrosis | 0.802 | 0.357 - 1.802 | 0.594 | 0.725 | 0.239 - 2.201 | 0.570 |
Focality (Multi vs Uni) | 2.310 | 0.539 - 9.902 | 0.259 | 3.217 | 0.551 - 18.76 | 0.194 |
Delay of NU | 1.819 | 0.759 - 4.358 | 0.179 | 0.777 | 0.234 - 2.571 | 0.679 |
Concomitant Bl UC | 4.800 | 1.868-12.34 | 0.001* | 15.01 | 3.311 - 68.07 | 0.0004* |
Diag. URS (yes vs no) | 1.809 | 0.681 - 4.802 | 0.234 | 1.840 | 0.482 - 7.019 | 0.372 |
Surgical margin | 1.916 | 0.715 - 5.129 | 0.195 | 1.775 | 0.299 - 10.52 | 0.527 |
Procedure (Lap vs open) | 2.358 | 0.319 - 17.41 | 0.400 | 2.265 | 0.163 - 31.34 | 0.541 |
Mitomycin C | 0.752 | 0.299 - 1.890 | 0.544 | 0.154 | 0.025 - 0.922 | 0.040* |
Adjuvant Chemotherapy | 0.932 | 0.275 - 3.154 | 0.910 | 1.256 | 0.174 - 9.044 | 0.820 |